Get started
Novo-Nordisk A/SNovo-Nordisk A/SNovo-Nordisk A/S

Novo-Nordisk A/S

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsForecastSeasonalsBondsETFs

NONOF trade ideas

Novo Nordisk Setup – Is This the Pharma Sector’s Strongest Play?🚀 NVO "Novo Nordisk" – Wealth Strategy Map (Swing/Day Trade) 📈 Trade Plan (Bullish Setup) Trend Confirmation: The bullish trend is supported by Dow Theory accumulation phase 📊. Candle Signal: A Heikin Ashi Doji has formed, adding confluence to the setup. Indicator Alert: LSMA (Least Squares Moving Average) line has confirmed a breakout, reinforcing the bullish case. 🎯 Entry Strategy (Layering Style) This plan uses a layered entry approach — placing multiple buy-limit orders across price levels to scale into the trade: Layered Buys: 54.00 → 55.00 → 56.00 → 57.00 (⚡ You can expand your limit layers further depending on your own preference and risk appetite.) ✅ This layered method allows flexibility, smoothing entries instead of relying on a single price level. 🛡️ Risk Management Stop Loss Idea: Suggested protective stop near 52.00 🔒. 📢 Note: Risk is personal! Adjust your SL to fit your risk tolerance, capital, and trading style. 🎯 Profit Target Target Zone: 66.00 (area of heavy resistance + possible overbought levels ⚡). ⚠️ Note: Exiting before the “crowd trap” forms is key — take profits wisely when conditions match your own plan. 🔗 Related Pairs to Watch NYSE:NVO (Primary) NYSE:LLY (Eli Lilly) 🧬 – Correlated pharma sector, often mirrors biotech sentiment. SP:SPX / AMEX:SPY 📊 – Broader market direction can impact large-cap pharma momentum. $USD/SEK 💱 – Novo Nordisk is Danish; currency fluctuations sometimes influence investor flow. Keeping an eye on these correlated assets can improve timing and risk management. ✨ “If you find value in my analysis, a 👍 and 🚀 boost is much appreciated — it helps me share more setups with the community!” #NVO #NovoNordisk #Stocks #SwingTrade #DayTrade #StockMarket #Bullish #HeikinAshi #DowTheory #TradingStrategy #PharmaStocks #LayeredEntries #RiskManagement
NYSE:NVOLong
by The-Thief
$NVO supertrend 3-5x in next 5 years- Don't trade NYSE:NVO but invest. - NYSE:NVO is in 28 years of uptrend and the innovation DNA of this company will prove the investors yet again. - Reasons to be bullish on NYSE:NVO - NYSE:NVO is making pills for weightloss but that not only helps in weight management but also reduces risk of heart attack, stroke, control diabetes. - Injections are costly to manufacture and has less shelf life on top of that in order to take injections one often require assistance whereas pills is very easy to consume just like vitamins. - NYSE:NVO move towards oral pills unlock massive TAM ( technical addressable market ) as millions of people are suffering with obesity, diabetes, chronic heart and brain disease that having access to this pill would be like getting a vitamin pill. - NYSE:NVO is like index fund for denmark just like NASDAQ:QQQ where majority of weight is taken by big tech stocks. Danish funds and people will continue to buy the dip regardless of whether NYSE:NVO is in bearish cycle or bullish. - NYSE:NVO valuation is super cheap and is even lower than NYSE:NVO started the injectibles for weight loss. - NYSE:NVO leadership is reflective and has conducted reduction in workforce which is rare for healthcare company as healthcare company usually run like welfare/government bloated. CEO is ready to keep startup like culture and promote innovation DNA alive. - I believe NYSE:NVO offers asymmetric opportunity and is going to be a long term compounder for years to come.
NYSE:NVOLong
by bigbull037
Why Did Novo Stock Fall So Sharply YesterdayNovo Nordisk shares plunged nearly 20–23% on July 29, 2025, marking its worst trading day since Black Monday in 1987. Significant Downgrade of 2025 Financial Outlook The company revised its sales growth forecast for 2025 down to 8–14%, from its prior guidance of 13–21%, and reduced expected operating profit growth from 16–24% to 10–16%. This adjustment was attributed to weaker-than-expected demand for Wegovy and Ozempic, and rising competitive pressures #TheWallStreetJournal I will start my accumulation using DCA, but will be happier to start buying this stock heavily from $47 zone. trade with care. I look forward to connecting with you
NYSE:NVOLong
by ForexClinik
1
NVO currently consolidatedNVO is a relatively popular stock that entered into a steep downward channel. It arrived at a key support zone that must be throughly tested in order to break out of said downward channel. A positive outlook is that it looks to be trading below fair value, but could be trading at $50 for next few months until the support is fully secured. This is a long play but if you buy dips in the $40-$50 range, in early-mid 2026 you could see good 2x or greater returns when the company gets back on track. Thoughts?
NYSE:NVOLong
by darkprince009
NVO Down 65% From Highs - Falling Knife or Value Play? Current Setup Price: $56.98 Position: Long since $48 Bullish Case Recent Bounce: NVO rebounded strongly from support near $45, reclaiming multiple EMA bands and pushing above key levels ($54–$55). RSI Momentum: RSI is trending upward from oversold territory, currently around 45.75—bullish momentum building but not overbought yet. Upside Targets: If the move holds, next resistance zones are $60.10, $60.50, and $61.83. Past those levels, open air toward $69.38 and $84.83 above. Bearish Case Downtrend Structure: Price still below major swing resistance ($69.38, $84.83, $96.60). Recent rallies could face rejection at EMA clusters. Trendline Threat: Failure to hold above $55–$60 could signal a retest of lower support ($45.05). Watch for bearish reversal candles. PMO: Top panel momentum indicators show recent green signals but remain in a zone where reversals have happened before—risk of overhead selling pressure. Bias Today: Slightly Bullish Why: Price action is turning up, reclaiming key levels after deep oversold conditions. Bears may defend resistance, but the risk-reward favors bulls unless $55 fails. Watch: $60.10–$61.83 are breakout levels. Above there, momentum can accelerate. Below $54, caution is warranted.
NYSE:NVOLong
by truthseeker6
Once in a Lifetime Opportunity and the Psychology behind itOnce in a Lifetime Opportunity and the Psychology behind it There are moments in the market that happen so rarely , they feel almost mythical when they finally arrive. Novo Nordisk NYSE:NVO has just given us one of those moments. If you’ve been following my work, you might remember my previous article where I warned that NVO was approaching a historically significant long-term yellow channel, a structure that has been respected for decades. In fact, the lower bound of this channel has only been touched less than once per decade. And here we are again… When price recently dipped into this “Ideal Buy Zone,” it wasn’t just touching the bottom of the yellow channel. It was also colliding with a red historical support level and the last significant VRVP volume area . That’s triple confluence , and as traders, we live for these rare alignments. I personally had the privilege (and yes, a bit of luck) to buy at $45.8 , on what turned out to be NVO’s worst single day in years. Seeing the double support, I didn’t hesitate. And judging by the market reaction, I wasn’t alone, many others seemed to spot the same opportunity. The Easy Part Is Over, Now Comes the Hardest Decision in Trading I might look like a genius for catching the bottom , but let’s be honest: buying was the easy part . The true challenge now? Deciding when to sell. Here are the main paths forward in my head: 1. The Short-Term Quick Win The stock rallied about 10% in just two days. Annualized, that return is insane. Selling would lock in a solid, risk-free gain and free up capital for the next opportunity. The downside? You might watch it keep climbing without you, and you know, that's SO HARD. ✅ Guarantees an amazing annualized return (about millions %!). ❌ You lose a once in a life-time potential upside with LOW risk. 2. The Split Strategy Sell half the position for a clean 10% profit , and let the other half ride. Set a tight stop-loss at $43.5 to protect the remaining capital. ✅ Guarantees a win on the trade while you keep upside exposure. ❌ Halves your potential upside. 3. The Long-Term Hold Hold the full position and see where it goes, perhaps for years. ✅ Maximum potential absolute gain if the channel continues to hold and trend upwards. ❌ Keeps capital locked and will test your nerves through constant ups and downs. And here’s the truth: whether I sell too early or too late, I will regret it one way or another. Nobody times the absolute top. The Risk of Doing Nothing There’s another factor that can’t be ignored: event risk. Without a stop-loss, a bad headline could turn a +10% gain into -10%, -20%, or worse. In trading, protecting capital is priority number one. So, What’s the Play? If similar opportunities exist elsewhere, ones with comparable risk/reward profiles, short-term exits can make a lot of sense . By rotating capital through multiple high-probability setups in a year, the annualized return potential is astonishing. Other Short-term ideas shared recently: I’ll share 3 examples of how I apply this rotation strategy to consistently generate strong annualized returns. For now, I’ll just say: rare touches of a decades-long channel are gifts… but the exit and the long term strategy is where traders are truly tested. 3,5% in 1 day in Sartorius 3% in 10 days in TJX 2,5% in 9 days But sometimes trades do not work as expected and then SL is crucial to avoid large loses, like EURUSD t hat yielded a-0,5% in few days: So, what do you think I'm doing with my "once in a life time" NYSE:NVO position? 💬 Does this setup align with your view on NYSE:NVO ? 🚀 Hit the rocket if this helped you spot the opportunity and follow for more easy, educational trade ideas!
NYSE:NVOLong
by TopChartPatterns
3
NVO Bulls Load $60 Calls for 100%+ Weekly Gains! # 🚀 NVO Weekly Options Trade Setup (08/24/2025) **Consensus:** 🔥 Strong Bullish — All 5 AI models favor weekly calls! **Market Context:** Low VIX (\~14.2) ✅, Heavy Call Flow (C/P 3.43) 📈, Institutional Volume ↑ 1.3x --- lish on weekly horizon * **Strategy:** Single‑leg weekly CALLs * **Expiry:** 2025‑08‑29 (exit by Thursday to avoid 1 DTE gamma/theta risk) * **Stop/Target:** Tight stops 40–50%, profit 50–100% * **Strike Recommendation:** \$60 CALL ✅ * Massive liquidity (Volume: 5,019; OI: 6,348) * Cheap entry, high leverage, low slippage * Aligns with Grok/xAI & liquidity preference --- ## ⚡ Trade Details (Ready to Execute) ```json { "instrument": "NVO", "direction": "call", "strike": 60.0, "expiry": "2025-08-29", "confidence": 0.78, "profit_target": 0.68, "stop_loss": 0.17, "size": 1, "entry_price": 0.34, "entry_timing": "open", "signal_publish_time": "2025-08-24 07:58:54 UTC-04:00" } ``` --- ## 📌 Quick-Trade Snapshot 🎯 **Instrument:** NVO 🔀 **Direction:** CALL (LONG) 💵 **Entry Price:** \$0.34 🎯 **Profit Target:** \$0.68 (+100%) 🛑 **Stop Loss:** \$0.17 (-50%) 📅 **Expiry:** 2025-08-29 📏 **Size:** 1 contract 📈 **Confidence:** 78% ⏰ **Entry:** Market Open Monday 🕒 **Signal Time:** 08/24/2025 07:59 EDT --- ## ⚠️ Risks & Notes * **Theta decay:** Exit by Thursday to avoid gamma/theta crush * **Binary events:** Check stock news/earnings * **Low premium = high loss probability:** Risk only what you can afford * **Stop execution:** Prefer mental + limit sell vs. automated stops
NYSE:NVOLong
by quantsignals
3
NVO Bullish Swing Incoming! Call Strike $55 🚀 NVO Swing Alert – 2025-08-15 🚀 **Sentiment:** Moderate Bullish **Setup:** Call Option Trade --- ## 📈 Market Snapshot * **Daily RSI:** 44.7 → Neutral but trending upward * **5 & 10-Day Trend:** +2.94% / +9.11% → Short-term bullish momentum * **Volume:** Avg (1.0x) → Weak breakout confirmation * **Call/Put Ratio:** 1.00 → Neutral market expectancy * **VIX:** 14.8 → Low volatility, favorable for directional trades --- ## ⚖️ Consensus & Conflicts **Agreement:** * Short-term positive performance suggests bullish potential * Low VIX environment favorable for swing trading **Disagreement:** * Mixed interpretation of Call/Put ratio * Some models caution due to weak volume and insufficient institutional support --- ## 🎯 Trade Setup – NVO CALL **Entry Condition:** At market open **Strike:** \$55.00 **Expiration:** 2025-08-29 **Entry Price:** \$0.91 **Confidence:** 72% **Profit Targets:** * Scale 50% at \$1.36 (50% gain) * Hold remainder until \$1.82 (100% potential gain) **Stop Loss:** \$0.54 (40% of premium) **Key Risks:** * Weak volume may limit momentum * Breach of \$50 support invalidates bullish setup --- ## 📝 TRADE DETAILS (JSON) ```json { "instrument": "NVO", "direction": "call", "strike": 55.0, "expiry": "2025-08-29", "confidence": 0.72, "profit_target": 1.36, "stop_loss": 0.54, "size": 1, "entry_price": 0.91, "entry_timing": "open", "signal_publish_time": "2025-08-15 13:54:27 UTC-04:00" } ``` --- ## 📊 Quick Reference – TradingView Ready 🎯 **Instrument:** NVO 🔀 **Direction:** CALL (Long) 💵 **Entry Price:** \$0.91 📈 **Profit Target:** \$1.36 / \$1.82 🛑 **Stop Loss:** \$0.54 📅 **Expiry:** 2025-08-29 📏 **Size:** 1 contract ⏰ **Entry Timing:** Market Open 🕒 **Signal Time:** 2025-08-15 13:54 EDT --- ### Suggested Viral Title & Tags: **🔥 NVO Swing Alert: Call Setup Ready – Strike \$55 🚀** \#NVO #SwingTrade #OptionsTrading #Bullish #CallOption #Momentum #TradeSetup #TechnicalAnalysis #StockAlerts #Finance #TradingSignals #MarketWatch #LongTrade
NYSE:NVOLong
by quantsignals
4
$NVO Elliott Wave Count – Eyeing $113 Before Big C-Wave DropPrimary Elliott Wave Scenario – NYSE:NVO I believe NYSE:NVO completed a multi-year Wave I in May 2024. Since then, we’ve seen the A-wave of a larger ABC correction play out. The price dipped below the 0.618 Fib at $56.63, but reclaimed key support at $47.75. My current primary count suggests that the bottom might already be in. The drop to $45 looks like an extended B-wave, hitting classic Fibonacci targets. If the bottom is confirmed, I expect a B-wave rally with a likely target range of $91.77–$113.19 — possibly even higher. This is not a short-term move; it will take time to develop. After the B-wave completes, I anticipate a final C-wave down to $47.75–$29, which would complete the Wave II correction. This would set up a major long-term buying opportunity for the years ahead. Invalidation: If price breaks below $45 again, this scenario is invalid. In that case, we likely head straight to $32 and the 0.786 Fib.
NYSE:NVO
by M-W-i
2
$NOV: Lot of loss in weight loss. Is it in buy zone? Currently the weight loss drugs are having a severe loss of weightage in the corresponding indices. The poster child of weight loss and diabetes drugs XETR:NOV and NYSE:LLY are seeing some of the worst drawdown in their history. Today we look at the worst of the 2 in this space which is $NOV. Novo Nordisk had a lot of missed steps in the current year, and the stock price has lost almost 70% from its peak of 148 $ in June of 2024. It has a long and painful drawdown of almost 70% from its ATH. The downward sloping pattern is so prominent that it is hard to ignore the drawdown in this stock. But the question comes will there me more loss and pain this weight loss pioneer or there is a visible buy zone for this stock. I did some unorthodox chart today plotting the downward slopping Fib retracement by joining the tops of the recent lower highs and on the lower bound of the lower lows. We see the clear levels provided by the Fib levels. Currently the stock is at 0.786 level with price at 49 $. I think once the key psychological level of 50 $ is broken the stock can go below the 0.786 level and may touch the 1.0 Fib level which is @ around 40 $. And with 0.618 being the upper limit with price 52 $. This range was also in play during 2021 and 2022 when the stock did a year long consolidation before moving higher. Verdict: XETR:NOV is within the accumulating zone with 52 $ as top and 40 $ as the bottom. 70 % drawdown from the top is a tempting discount on the price and a good entry point for long term.
NYSE:NVOLong
by RabishankarBiswal
NovoNordisk, possible rotation,safe green buy Zone after confirmNovo Nordisk got slammed after Patrick appeared in the Technical analysis and slammed the Price all the way down to goblintown. After some profit cuts and FUD in the market a possibly rotation is possible. The GLP-1 market is misunderstood. if a rotation is confirmed and some more facts will be shared after lilly earnings today a possible rotation and green buy zone will be confirmed. after new facts and confirmation a High risk/reward oppertunity is possible. Let's all hope patrick will appear back again (maybe after lilly earnings) in the charts and will take everyting upside down. Good luck.
NYSE:NVOLong
by jornwaterlander